WANG Guangyu, YAN Junfang, WANG Zhiqun, ZHANG Yu, SUN Xiansong, LI Jing, LI Wenbo, YANG Bo, ZHANG Fuquan. Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1101-1105. DOI: 10.12290/xhyxzz.2023-0076
Citation: WANG Guangyu, YAN Junfang, WANG Zhiqun, ZHANG Yu, SUN Xiansong, LI Jing, LI Wenbo, YANG Bo, ZHANG Fuquan. Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1101-1105. DOI: 10.12290/xhyxzz.2023-0076

Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report

Funds: 

National Key Research and Development Program of China 2022YFC2407100

National Key Research and Development Program of China 2022YFC2407101

National Key Research and Development Program of China 2022YFC2407102

More Information
  • Corresponding author:

    YAN Junfang, E-mail: yanjunfang@pumch.cn

  • Received Date: February 12, 2023
  • Accepted Date: March 27, 2023
  • Available Online: August 03, 2023
  • Issue Publish Date: September 29, 2023
  • Online adaptive radiotherapy(OART)is considered to be a revolutionary technology after intensity-modulated radiotherapy. The first Chinese OART platform based on iterative cone beam computed tomography (iCBCT)has been applied in clinical treatment in Peking Union Medical College Hospital. This article reports the workflow and efficacy of first case with cervical cancer who received radical OART. After treatment, the patient achieved clinical complete remission with only a grade 1 radiation toxicity in the lower gastrointestinal tract. This article analyzes and discusses the clinical treatment process and follow-up data of this patient, aiming to provide clinical evidence for the subsequent large-scale application of artificial intelligence-driven iCBCT-guided OART technology.
  • [1]
    Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71: 209-249. DOI: 10.3322/caac.21660
    [2]
    Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424. DOI: 10.3322/caac.21492
    [3]
    Naga Ch P, Gurram L, Chopra S, et al. The management of locally advanced cervical cancer[J]. Curr Opin Oncol, 2018, 30: 323-329. DOI: 10.1097/CCO.0000000000000471
    [4]
    Klopp AH, Yeung AR, Deshmukh S, et al. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203[J]. J Clin Oncol, 2018, 36: 2538-2544. DOI: 10.1200/JCO.2017.77.4273
    [5]
    Chopra S, Gupta S, Kannan S, et al. Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial[J]. J Clin Oncol, 2021, 39: 3682-3692. DOI: 10.1200/JCO.20.02530
    [6]
    Gandhi AK, Sharma DN, Rath GK, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study[J]. Int J Radiat Oncol Biol Phys, 2013, 87: 542-548. DOI: 10.1016/j.ijrobp.2013.06.2059
    [7]
    Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer[J]. Clin Oncol (R Coll Radiol), 2014, 26: 185-196. DOI: 10.1016/j.clon.2013.11.031
    [8]
    Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects[J]. Mol Oncol, 2020, 14: 1538-1554. DOI: 10.1002/1878-0261.12750
    [9]
    Hale MF. Radiation enteritis: from diagnosis to management[J]. Curr Opin Gastroenterol, 2020, 36: 208-214. DOI: 10.1097/MOG.0000000000000632
    [10]
    Åström LM, Behrens CP, Storm KS, et al. Online adaptive radiotherapy of anal cancer: Normal tissue sparing, target propagation methods, and first clinical experience[J]. Radiother Oncol, 2022, 176: 92-98. DOI: 10.1016/j.radonc.2022.09.015
    [11]
    Christiansen RL, Dysager L, Hansen CR, et al. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment[J]. Radiother Oncol, 2022, 167: 165-171. DOI: 10.1016/j.radonc.2021.12.013
    [12]
    Kerkhof EM, Raaymakers BW, van der Heide UA, et al. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study[J]. Radiother Oncol, 2008, 88: 241-249. DOI: 10.1016/j.radonc.2008.04.009
    [13]
    Bertelsen AS, Schytte T, Møller PK, et al. First clinical experiences with a high field 1.5 T MR linac[J]. Acta Oncol, 2019, 58: 1352-1357. DOI: 10.1080/0284186X.2019.1627417
    [14]
    Alongi F, Rigo M, Figlia V, et al. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment[J]. Radiat Oncol, 2020, 15: 69. DOI: 10.1186/s13014-020-01510-w
    [15]
    de Jong R, Visser J, van Wieringen N, et al. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer[J]. Radiat Oncol, 2021, 16: 136. DOI: 10.1186/s13014-021-01866-7

Catalog

    Article Metrics

    Article views (429) PDF downloads (52) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close